VEGFA and diabetic retinopathy: Ocular drug delivery is a promising route to deliver drugs used for the treatment of several ocular diseases, such as diabetic retinopathy, which is triggered by inflammation and increased levels of vascular endothelial growth factor (VEGF) or neovascularization.